The Prognosis of Primary Percutaneous Coronary Intervention after One Year Clinical Follow Up

被引:0
作者
Dadjoo, Yahya [1 ]
Mahmoodi, Yadallah [1 ]
机构
[1] Bagheiatallah Univ Med Sci, Cardiovasc Res Ctr, Tehran, Iran
关键词
Myocardial Infarction; Intervention; Mortality;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The aim of this study was to evaluate the clinical outcomes, one year after primary percutaneous coronary intervention(PCI). Patients and Methods: From September 2009 to March 2012, primary PCI was performed on 70 cases, and the data relating to their catheterization were recorded. Peri-interventional treatment data included PCI with drug-eluting or bare-metal stent or balloon angioplasty alone. Results: The mean age of the patients was 61.34+11.31 years, and 72.9% of them were males. The ratios of patients with diabetes, hypertension and, hyperlipidemia were 61.4%, 71.4%, and 52.9% respectively. In clinical follow-up, total incidence of death was 4.3%, with no death occurring during 30 days. However, 3 patients died after one-year, of which one patient (1.4%) had cardiac problem and the other 2 (2.9%) died because of non-cardiac reasons. Target vessel revascularization, reinfarction within 30 days, and mechanical complication or stroke were not found in any of the patients. Patients with hypertension (6%) and those with LAD ST-elevation myocardial infarction (5%) died after one year (P=0.263 and P=0.319 respectively). However, no mortality was reported in patients with RCA and LCX ST-elevation myocardial infarction. Of subjects with multivessel disease, 7% died after one-year (P=0.161), but there was no reported mortality in those with single vessel disease. Conclusions: The prognosis was satisfactory in patients undergoing PCI after one year clinical follow up.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 27 条
[1]   Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty [J].
Antoniucci, D ;
Valenti, R ;
Migliorini, A ;
Moschi, G ;
Trapani, M ;
Buonamici, P ;
Cerisano, G ;
Bolognese, L ;
Santoro, GM .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (11) :1248-1252
[2]   Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial [J].
Chen, ZM ;
Jiang, LX ;
Chen, YP ;
Xie, JX ;
Pan, HC ;
Peto, R ;
Collins, R ;
Liu, LS ;
Chen, ZM ;
Liu, LS ;
Collins, R ;
Jiang, LX ;
Chen, YP ;
Xie, JX ;
Pan, HC ;
Peto, R ;
Cai, NS ;
Chen, YZ ;
Cui, JJ ;
Dai, GZ ;
Feng, JZ ;
Fu, SY ;
Gent, M ;
Gong, LS ;
Hu, DY ;
Huang, DJ ;
Huang, J ;
Huang, TG ;
Huang, ZW ;
Hui, RT ;
Jiang, BQ ;
Li, DY ;
Li, SM ;
Li, TD ;
Li, YQ ;
Li, ZQ ;
Liu, YH ;
Meng, QY ;
Qian, TJ ;
San, J ;
Tao, SQ ;
Wang, DW ;
Wang, LH ;
Wang, W ;
Wu, HA ;
Xi, WH ;
Xu, CB ;
Yang, DC ;
Yang, XF ;
Yin, JQ .
LANCET, 2005, 366 (9497) :1607-1621
[3]   Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction -: Data from the French registry on acute ST-elevation myocardial infarction (FAST-MI) [J].
Danchin, Nicolas ;
Coste, Pierre ;
Ferrieres, Jean ;
Steg, Philippe-Gabriel ;
Cottin, Yves ;
Blanchard, Didier ;
Belle, Loic ;
Ritz, Bernard ;
Kirkorian, Gilbert ;
Angioi, Michael ;
Sans, Philippe ;
Charbonnier, Bernard ;
Eltchaninoff, Helene ;
Gueret, Pascal ;
Khalife, Khalife ;
Asseman, Philippe ;
Puel, Jacques ;
Goldstein, Patrick ;
Cambou, Jean-Pierre ;
Simon, Tabassome .
CIRCULATION, 2008, 118 (03) :268-276
[4]   Pharmacologic Therapy for Non ST-segment Elevation Acute Coronary Syndromes: Focus on Antithrombotic Therapy [J].
Danchin, Nicolas ;
Aissaoui, Nadia .
CARDIOVASCULAR DRUGS AND THERAPY, 2010, 24 (04) :325-330
[5]   Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction - A meta-analysis of randomized trials [J].
De Luca, G ;
Suryapranata, H ;
Stone, GW ;
Antoniucci, D ;
Tcheng, JE ;
Neumann, FJ ;
Van de Werf, F ;
Antman, EM ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14) :1759-1765
[6]   Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty [J].
De Luca, G ;
Suryapranata, H ;
Zijlstra, F ;
van't Hof, AWJ ;
Hoorntje, JCA ;
Gosselink, ATM ;
Dambrink, JH ;
de Boer, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (06) :991-997
[7]   Trends in Door-to-Balloon Time and Mortality in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [J].
Flynn, Anneliese ;
Moscucci, Mauro ;
Share, David ;
Smith, Dean ;
LaLonde, Thomas ;
Changezi, Hameem ;
Riba, Arthur ;
Gurm, Hitinder S. .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (20) :1842-1849
[8]   The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice [J].
Flynn, MR ;
Barrett, C ;
Cosío, FG ;
Gitt, AK ;
Wallentin, L ;
Kearney, P ;
Lonergan, M ;
Shelley, E ;
Simoons, ML .
EUROPEAN HEART JOURNAL, 2005, 26 (03) :308-313
[9]   A European perspective on improving acute systems of care in STEMI: we know what to do, but how can we do it? [J].
Fox, Keith A. A. ;
Huber, Kurt .
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2008, 5 (11) :708-714
[10]   Fibrinolytic therapy - Is it a treatment of the past? [J].
Grines, CL ;
Serruys, P ;
O'Neill, WW .
CIRCULATION, 2003, 107 (20) :2538-2542